Skip to main content
Top
Published in: Gastric Cancer 2/2024

Open Access 11-01-2024 | Epstein-Barr Virus | Original Article

Sex-dependent different clinicopathological characterization of Epstein–Barr virus-associated gastric carcinoma: a large-scale study

Authors: Ji-Hyun Kim, Nayoung Kim, Du Hyun Song, Yonghoon Choi, Eun-Bi Jeon, Sihyun Kim, Yu Kyung Jun, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee, Hyeon Jeong Oh, Hye Seung Lee, Young Suk Park, Sang-Hoon Ahn, Yun-Suhk Suh, Do Joong Park, Hyung Ho Kim, Ji-Won Kim, Jin Won Kim, Keun-Wook Lee, Won Chang, Ji Hoon Park, Yoon Jin Lee, Kyoung Ho Lee, Young Hoon Kim, Soyeon Ahn

Published in: Gastric Cancer | Issue 2/2024

Login to get access

Abstract

Background

Epstein–Barr virus (EBV)-associated gastric cancer (EBVaGC) has been reported to account for approximately 5–16% of all GCs with good prognosis compared to EBV-negative GC. We evaluated the clinicopathological characteristics of EBVaGC including survival rate in South Korea.

Methods

A total of 4,587 patients with GC who underwent EBV in situ hybridization (EBV–ISH) were prospectively enrolled at the Seoul National University Bundang Hospital from 2003 to 2021. Age, sex, smoking status, cancer type and stage, tumor size and location, histological type, molecular features and survival information were analyzed.

Results

A total of 456 patients with GC (9.9%) were positive for EBV. The EBVaGC group displayed a higher proportion of males (P < 0.001), a predominant presence in the proximal stomach (P < 0.001), a higher proportion of undifferentiated cancer (P < 0.001), and a lower cancer stage (P = 0.004) than the EBV-negative group. Cox multivariate analyses revealed age (hazard ratio [HR] = 1.025, P < 0.001), tumor size (HR = 1.109, P < 0.001), and cancer stage (stage2 HR = 4.761, P < 0.001; stage3 HR = 13.286, P < 0.001; stage4 HR = 42.528, P < 0.001) as significant risk factors for GC-specific mortality, whereas EBV positivity was inversely correlated (HR = 0.620, P = 0.022). Furthermore, the EBVaGC group displayed statistically significant survival advantages over the EBV-negative cancer group in terms of both overall (P = 0.021) and GC-specific survival (P = 0.007) on the Kaplan–Meier survival curve. However, this effect was evident only in males.

Conclusions

EBVaGC patients showed better prognoses despite their association with proximal location and poorly differentiated histology in male, probably due to the difference in immunity between males and females.
Literature
1.
2.
go back to reference Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–9.CrossRefADS Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–9.CrossRefADS
5.
go back to reference IARC (1997) Epstein-Barr virus and Kaposi’s sarcoma herpesvirus/human herpesvirus 8, IARC, Lyon, France. pp. 47–262. IARC (1997) Epstein-Barr virus and Kaposi’s sarcoma herpesvirus/human herpesvirus 8, IARC, Lyon, France. pp. 47–262.
6.
go back to reference Tsao SW, Tsang CM, To KF, Lo KW. The role of Epstein-Barr virus in epithelial malignancies. J Pathol. 2015;235:323–33.PubMedCrossRef Tsao SW, Tsang CM, To KF, Lo KW. The role of Epstein-Barr virus in epithelial malignancies. J Pathol. 2015;235:323–33.PubMedCrossRef
7.
go back to reference Chen XZ, Chen H, Castro FA, Hu JK, Brenner H. Epstein-Barr virus infection and gastric cancer: a systematic review. Medicine (Baltimore). 2015;94: e792.PubMedCrossRef Chen XZ, Chen H, Castro FA, Hu JK, Brenner H. Epstein-Barr virus infection and gastric cancer: a systematic review. Medicine (Baltimore). 2015;94: e792.PubMedCrossRef
8.
go back to reference Burke AP, Yen TS, Shekitka KM, Sobin LH. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol. 1990;3:377–80.PubMed Burke AP, Yen TS, Shekitka KM, Sobin LH. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol. 1990;3:377–80.PubMed
9.
go back to reference Bae JM, Kim EH. Epstein-Barr virus and gastric cancer risk: a meta-analysis with meta-regression of case-control studies. J Prev Med Public Health. 2016;49:97–107.PubMedPubMedCentralCrossRef Bae JM, Kim EH. Epstein-Barr virus and gastric cancer risk: a meta-analysis with meta-regression of case-control studies. J Prev Med Public Health. 2016;49:97–107.PubMedPubMedCentralCrossRef
10.
go back to reference Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21:449–56.PubMedCrossRef Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21:449–56.PubMedCrossRef
11.
go back to reference Naseem M, Barzi A, Brezden-Masley C, Puccini A, Berger MD, Tokunaga R, et al. Outlooks on Epstein-Barr virus associated gastric cancer. Cancer Treat Rev. 2018;66:15–22.PubMedPubMedCentralCrossRef Naseem M, Barzi A, Brezden-Masley C, Puccini A, Berger MD, Tokunaga R, et al. Outlooks on Epstein-Barr virus associated gastric cancer. Cancer Treat Rev. 2018;66:15–22.PubMedPubMedCentralCrossRef
12.
go back to reference Kim YS, Nam SC, Han MH, Jeong JY, Park SK, Suh IS, et al. Predictive factors of Epstein-Barr virus association in gastric adenocarcinoma. Korean J Pathol. 2008;42:193–7. Kim YS, Nam SC, Han MH, Jeong JY, Park SK, Suh IS, et al. Predictive factors of Epstein-Barr virus association in gastric adenocarcinoma. Korean J Pathol. 2008;42:193–7.
13.
go back to reference Camargo MC, Kim KM, Matsuo K, Torres J, Liao LM, Morgan DR, et al. Anti-Helicobacter pylori antibody profiles in Epstein-Barr virus (EBV)- positive and EBV-negative gastric cancer. Helicobacter. 2016;21:153–7.PubMedCrossRef Camargo MC, Kim KM, Matsuo K, Torres J, Liao LM, Morgan DR, et al. Anti-Helicobacter pylori antibody profiles in Epstein-Barr virus (EBV)- positive and EBV-negative gastric cancer. Helicobacter. 2016;21:153–7.PubMedCrossRef
14.
go back to reference van Beek J, Zur Hausen A, Klein Kranenbarg E, van de Velde CJ, Middeldorp JM, van den Brule AJ, et al. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol. 2004;22:664–70.PubMedCrossRef van Beek J, Zur Hausen A, Klein Kranenbarg E, van de Velde CJ, Middeldorp JM, van den Brule AJ, et al. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol. 2004;22:664–70.PubMedCrossRef
15.
go back to reference Li S, Du H, Wang Z, Zhou L, Zhao X, Zeng Y. Meta-analysis of the relationship between Epstein-Barr virus infection and clinicopathological features of patients with gastric carcinoma. Sci China Life Sci. 2010;53:524–30.PubMedCrossRef Li S, Du H, Wang Z, Zhou L, Zhao X, Zeng Y. Meta-analysis of the relationship between Epstein-Barr virus infection and clinicopathological features of patients with gastric carcinoma. Sci China Life Sci. 2010;53:524–30.PubMedCrossRef
16.
go back to reference Murphy G, Pfeiffer R, Camargo MC, Rabkin CS. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology. 2009;137:824–33.PubMedCrossRef Murphy G, Pfeiffer R, Camargo MC, Rabkin CS. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology. 2009;137:824–33.PubMedCrossRef
17.
go back to reference Kijima Y, Ishigami S, Hokita S, Koriyama C, Akiba S, Eizuru Y, et al. The comparison of the prognosis between Epstein-Barr virus (EBV)-positive gastric carcinomas and EBV-negative ones. Cancer Lett. 2003;200:33–40.PubMedCrossRef Kijima Y, Ishigami S, Hokita S, Koriyama C, Akiba S, Eizuru Y, et al. The comparison of the prognosis between Epstein-Barr virus (EBV)-positive gastric carcinomas and EBV-negative ones. Cancer Lett. 2003;200:33–40.PubMedCrossRef
18.
go back to reference Camargo MC, Koriyama C, Matsuo K, Kim WH, Herrera-Goepfert R, Liao LM, et al. Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus-positive gastric cancer. Int J Cancer. 2014;134:948–53.PubMedCrossRef Camargo MC, Koriyama C, Matsuo K, Kim WH, Herrera-Goepfert R, Liao LM, et al. Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus-positive gastric cancer. Int J Cancer. 2014;134:948–53.PubMedCrossRef
19.
go back to reference Kayamba V, Monze M, Asombang AW, Zyambo K, Kelly P. Serological response to Epstein-Barr virus early antigen is associated with gastric cancer and human immunodeficiency virus infection in Zambian adults: a case-control study. Pan Afr Med J. 2016;23:45.PubMedPubMedCentralCrossRef Kayamba V, Monze M, Asombang AW, Zyambo K, Kelly P. Serological response to Epstein-Barr virus early antigen is associated with gastric cancer and human immunodeficiency virus infection in Zambian adults: a case-control study. Pan Afr Med J. 2016;23:45.PubMedPubMedCentralCrossRef
20.
go back to reference Ignatova E, Seriak D, Fedyanin M, Tryakin A, Pokataev I, Menshikova S, et al. Epstein-Barr virus-associated gastric cancer: disease that requires special approach. Gastric Cancer. 2020;23:951–60.PubMedCrossRef Ignatova E, Seriak D, Fedyanin M, Tryakin A, Pokataev I, Menshikova S, et al. Epstein-Barr virus-associated gastric cancer: disease that requires special approach. Gastric Cancer. 2020;23:951–60.PubMedCrossRef
21.
go back to reference Kim HJ, Hwang SW, Kim N, Yoon H, Shin CM, Park YS, et al. Helicobacter pylori and molecular markers as prognostic indicators for gastric cancer in Korea. J Cancer Preven. 2014;19:56–67.CrossRef Kim HJ, Hwang SW, Kim N, Yoon H, Shin CM, Park YS, et al. Helicobacter pylori and molecular markers as prognostic indicators for gastric cancer in Korea. J Cancer Preven. 2014;19:56–67.CrossRef
22.
go back to reference Lee JH, Kim SH, Han SH, An JS, Lee ES, Kim YS. Clinicopathological and molecular characteristics of Epstein-Barr virus associated gastric carcinoma: a meta-analysis. J Gastroenterol Hepatol. 2009;24:354–65.PubMedCrossRef Lee JH, Kim SH, Han SH, An JS, Lee ES, Kim YS. Clinicopathological and molecular characteristics of Epstein-Barr virus associated gastric carcinoma: a meta-analysis. J Gastroenterol Hepatol. 2009;24:354–65.PubMedCrossRef
23.
go back to reference Tokunaga M, Land CE. Epstein-Barr virus involvement in gastric cancer: biomarker for lymph node metastasis. Cancer Epidemiol Biomarkers Prev. 1998;7:449–50.PubMed Tokunaga M, Land CE. Epstein-Barr virus involvement in gastric cancer: biomarker for lymph node metastasis. Cancer Epidemiol Biomarkers Prev. 1998;7:449–50.PubMed
24.
go back to reference Camargo MC, Kim WH, Chiaravalli AM, Kim KM, Corvalan AH, Matsuo K, et al. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut. 2014;63:236–43.PubMedCrossRef Camargo MC, Kim WH, Chiaravalli AM, Kim KM, Corvalan AH, Matsuo K, et al. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut. 2014;63:236–43.PubMedCrossRef
25.
go back to reference Tokunaga M, Uemura Y, Tokudome T, Ishidate T, Masuda H, Okazaki E, et al. Epstein-Barr virus related gastric cancer in Japan: a molecular patho-epidemiological study. Acta Pathol Jpn. 1993;43:574–81.PubMed Tokunaga M, Uemura Y, Tokudome T, Ishidate T, Masuda H, Okazaki E, et al. Epstein-Barr virus related gastric cancer in Japan: a molecular patho-epidemiological study. Acta Pathol Jpn. 1993;43:574–81.PubMed
26.
go back to reference Sohn BH, Hwang JE, Jang HJ, Lee HS, Oh SC, Shim JJ, et al. Clinical significance of four molecular subtypes of gastric cancer identified by the cancer genome atlas project. Clin Cancer Res. 2017;23:4441–9.PubMedPubMedCentralCrossRef Sohn BH, Hwang JE, Jang HJ, Lee HS, Oh SC, Shim JJ, et al. Clinical significance of four molecular subtypes of gastric cancer identified by the cancer genome atlas project. Clin Cancer Res. 2017;23:4441–9.PubMedPubMedCentralCrossRef
27.
go back to reference Uemura Y, Tokunaga M, Arikawa J, Yamamoto N, Hamasaki Y, Tanaka S, et al. A unique morphology of Epstein-Barr virus related early gastric carcinoma. Cancer Epidemiol Biomarkers Prev. 1994;3:607–11.PubMed Uemura Y, Tokunaga M, Arikawa J, Yamamoto N, Hamasaki Y, Tanaka S, et al. A unique morphology of Epstein-Barr virus related early gastric carcinoma. Cancer Epidemiol Biomarkers Prev. 1994;3:607–11.PubMed
28.
go back to reference Song HJ, Srivastava A, Lee J, Kim YS, Kim KM, Ki Kang W, et al. Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma. Gastroenterology. 2010;139:84-92.e2.PubMedCrossRef Song HJ, Srivastava A, Lee J, Kim YS, Kim KM, Ki Kang W, et al. Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma. Gastroenterology. 2010;139:84-92.e2.PubMedCrossRef
29.
go back to reference Choi Y, Kim N, Kim KW, Jo HH, Park J, Yoon H, et al. Sex-based differences in histology, staging, and prognosis among 2983 gastric cancer surgery patients. World J Gastroenterol. 2022;28:933–47.PubMedPubMedCentralCrossRef Choi Y, Kim N, Kim KW, Jo HH, Park J, Yoon H, et al. Sex-based differences in histology, staging, and prognosis among 2983 gastric cancer surgery patients. World J Gastroenterol. 2022;28:933–47.PubMedPubMedCentralCrossRef
30.
go back to reference Jung YJ, Kim HJ, Park CH, Park SJ, Kim N. Effects of reproductive factors on Lauren intestinal-type gastric cancers in females: a multicenter retrospective study in South Korea. Gut Liver. 2022;16:706–15.PubMedPubMedCentralCrossRef Jung YJ, Kim HJ, Park CH, Park SJ, Kim N. Effects of reproductive factors on Lauren intestinal-type gastric cancers in females: a multicenter retrospective study in South Korea. Gut Liver. 2022;16:706–15.PubMedPubMedCentralCrossRef
31.
32.
go back to reference Araujo JM, Rosas G, Belmar-López C, Raez LE, Rolfo CD, Schwarz LJ, et al. Influence of sex in the molecular characteristics and outcomes of malignant tumors. Front Oncol. 2021;19(11): 752918.CrossRef Araujo JM, Rosas G, Belmar-López C, Raez LE, Rolfo CD, Schwarz LJ, et al. Influence of sex in the molecular characteristics and outcomes of malignant tumors. Front Oncol. 2021;19(11): 752918.CrossRef
33.
go back to reference Tokunaga M, Land CE, Uemura Y, Tokudome T, Tanaka S, Sato E. Epstein-Barr virus in gastric carcinoma. Am J Pathol. 1993;143:1250–4.PubMedPubMedCentral Tokunaga M, Land CE, Uemura Y, Tokudome T, Tanaka S, Sato E. Epstein-Barr virus in gastric carcinoma. Am J Pathol. 1993;143:1250–4.PubMedPubMedCentral
34.
go back to reference Park JH, Kim EK, Kim YH, Kim JH, Bae YS, Lee YC, et al. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa invasive early gastric cancer. Gastric Cancer. 2016;19:1041–51.PubMedCrossRef Park JH, Kim EK, Kim YH, Kim JH, Bae YS, Lee YC, et al. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa invasive early gastric cancer. Gastric Cancer. 2016;19:1041–51.PubMedCrossRef
35.
go back to reference Cheng Y, Zhou X, Xu K, Huang J, Huang Q. Very low risk of lymph node metastasis in Epstein-Barr virus-associated early gastric carcinoma with lymphoid stroma. BMC Gastroenterol. 2020;20:273.PubMedPubMedCentralCrossRef Cheng Y, Zhou X, Xu K, Huang J, Huang Q. Very low risk of lymph node metastasis in Epstein-Barr virus-associated early gastric carcinoma with lymphoid stroma. BMC Gastroenterol. 2020;20:273.PubMedPubMedCentralCrossRef
36.
go back to reference Lim H, Lee IS, Lee JH, Park YS, Kang HJ, Na HK, et al. Clinical application of early gastric carcinoma with lymphoid stroma based on lymph node metastasis status. Gastric Cancer. 2017;20:793–801.PubMedCrossRef Lim H, Lee IS, Lee JH, Park YS, Kang HJ, Na HK, et al. Clinical application of early gastric carcinoma with lymphoid stroma based on lymph node metastasis status. Gastric Cancer. 2017;20:793–801.PubMedCrossRef
37.
38.
go back to reference Watanabe H, Enjoji M, Imai T. Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations. Cancer. 1976;38:232–43.PubMedCrossRef Watanabe H, Enjoji M, Imai T. Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations. Cancer. 1976;38:232–43.PubMedCrossRef
39.
go back to reference Tak DH, Jeong HY, Seong JK, Moon HS, Kang SH. Comparison of clinical characteristics and prognostic factors between gastric lymphoepithelioma-like carcinoma and gastric adenocarcinoma. Korean J Gastroenterol. 2013;62:272–7.PubMedCrossRef Tak DH, Jeong HY, Seong JK, Moon HS, Kang SH. Comparison of clinical characteristics and prognostic factors between gastric lymphoepithelioma-like carcinoma and gastric adenocarcinoma. Korean J Gastroenterol. 2013;62:272–7.PubMedCrossRef
40.
go back to reference Kang BW, Seo AN, Yoon S, Bae HI, Jeon SW, Kwon OK, et al. Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer. Ann Oncol. 2016;27:494–501.PubMedCrossRef Kang BW, Seo AN, Yoon S, Bae HI, Jeon SW, Kwon OK, et al. Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer. Ann Oncol. 2016;27:494–501.PubMedCrossRef
41.
go back to reference Kim N. Sex/gender-specific medicine for intestinal type, and diffuse-type gastric cancer. In: Kim N, editor. Sex/gender-specific medicine in the gastrointestinal diseases. Singapore: Springer; 2022. p. 153–68.CrossRef Kim N. Sex/gender-specific medicine for intestinal type, and diffuse-type gastric cancer. In: Kim N, editor. Sex/gender-specific medicine in the gastrointestinal diseases. Singapore: Springer; 2022. p. 153–68.CrossRef
42.
go back to reference Jung YJ, Kim HJ, Park CH, Park SJ, Kim N. Effects of female reproductive factors on Lauren intestinal-type gastric cancer; a multicenter retrospective study in South Korea. Gut Liver. 2022;16:706–15.PubMedPubMedCentralCrossRef Jung YJ, Kim HJ, Park CH, Park SJ, Kim N. Effects of female reproductive factors on Lauren intestinal-type gastric cancer; a multicenter retrospective study in South Korea. Gut Liver. 2022;16:706–15.PubMedPubMedCentralCrossRef
43.
go back to reference Clausen F, Behrens HM, Krüger S, Röcken C. Sexual dimorphism in gastric cancer: tumor-associated neutrophils predict patient outcome only for women. J Cancer Res Clin Oncol. 2020;146:53–66.PubMedCrossRef Clausen F, Behrens HM, Krüger S, Röcken C. Sexual dimorphism in gastric cancer: tumor-associated neutrophils predict patient outcome only for women. J Cancer Res Clin Oncol. 2020;146:53–66.PubMedCrossRef
Metadata
Title
Sex-dependent different clinicopathological characterization of Epstein–Barr virus-associated gastric carcinoma: a large-scale study
Authors
Ji-Hyun Kim
Nayoung Kim
Du Hyun Song
Yonghoon Choi
Eun-Bi Jeon
Sihyun Kim
Yu Kyung Jun
Hyuk Yoon
Cheol Min Shin
Young Soo Park
Dong Ho Lee
Hyeon Jeong Oh
Hye Seung Lee
Young Suk Park
Sang-Hoon Ahn
Yun-Suhk Suh
Do Joong Park
Hyung Ho Kim
Ji-Won Kim
Jin Won Kim
Keun-Wook Lee
Won Chang
Ji Hoon Park
Yoon Jin Lee
Kyoung Ho Lee
Young Hoon Kim
Soyeon Ahn
Publication date
11-01-2024
Publisher
Springer Nature Singapore
Published in
Gastric Cancer / Issue 2/2024
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-023-01460-8

Other articles of this Issue 2/2024

Gastric Cancer 2/2024 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.